AVALO THERAPEUTICS INC (AVTX)

US05338F3064 - Common Stock

16.88  +0.94 (+5.9%)

After market: 16.9 +0.02 (+0.12%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
1.92M18.05M5.40M6.70M6.75M
Cost Of Goods
1.28M3.43M1.49M300.00K-570.00K
Gross Profit
640.00K14.62M3.91M6.40M7.32M
Operating Expenses
24.08M52.06M86.04M53.69M23.46M
Research and Development
13.78M31.31M59.84M32.19M11.76M
Selling, General, and Administrative Expenses
10.30M20.71M24.66M19.76M11.61M
Operating Income
-23.44M-37.44M-82.13M-47.29M-16.14M
Interest Income/Expense
-4.14M-4.17M-2.39M5.26M170.00K
Other Income/Expense
-42.00K-20.00K-20.00K410.00K-20.00K
Non Recurring Items
-3.91MN/A0.00-25.55M0.00
Income Before Taxes
-31.53M-41.63M-84.55M-67.18M-15.99M
Income Tax
14.00K30.00K-200.00K-2.79M280.00K
Net Income
-31.54M-41.66M-84.38M-63.50M-16.07M
EBITDA
-23.29M-37.27M-80.47M-45.45M-12.26M
 
Per Share Data
EPS Diluted Total Ops
-113.58-4.43-10.13-11.42-4.50
Non GAAP EPS
-488.22-253.04-9.96-10.56-3.36
 
Statistics
Gross Profit Margin
33.26%81.00%72.41%95.52%108.44%
Profit Margin
-1639.50%-230.80%-1562.59%-947.76%-238.07%
Operating Profit Margin
-1218.50%-207.42%-1520.93%-705.82%-239.11%

All data in USD

Charts